KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 153 filers reported holding KURA ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $318 | +23.3% | 34,867 | +43.1% | 0.00% | – |
| Q2 2023 | $258 | -11.3% | 24,368 | +2.6% | 0.00% | – |
| Q1 2023 | $291 | +2.8% | 23,760 | +4.3% | 0.00% | – |
| Q4 2022 | $283 | -99.9% | 22,785 | -14.8% | 0.00% | – |
| Q3 2022 | $366,000 | -47.2% | 26,748 | -29.2% | 0.00% | – |
| Q2 2022 | $693,000 | +15.3% | 37,796 | +1.1% | 0.00% | – |
| Q1 2022 | $601,000 | +94.5% | 37,373 | +69.3% | 0.00% | – |
| Q4 2021 | $309,000 | -58.1% | 22,077 | -43.9% | 0.00% | – |
| Q3 2021 | $737,000 | +7.1% | 39,355 | +19.2% | 0.00% | – |
| Q2 2021 | $688,000 | -23.3% | 33,019 | +4.0% | 0.00% | – |
| Q1 2021 | $897,000 | +15.3% | 31,746 | +33.3% | 0.00% | – |
| Q4 2020 | $778,000 | +21.6% | 23,822 | +14.0% | 0.00% | – |
| Q3 2020 | $640,000 | – | 20,896 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 3,766,852 | $57,633,000 | 6.49% |
| GREAT POINT PARTNERS LLC | 2,197,283 | $33,618,000 | 5.74% |
| Sio Capital Management, LLC | 392,027 | $5,998,000 | 3.38% |
| BVF INC/IL | 1,353,846 | $20,714,000 | 2.50% |
| Boxer Capital, LLC | 844,789 | $12,925,000 | 2.36% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 89,673 | $1,372,000 | 2.18% |
| Minerva Advisors LLC | 170,921 | $2,607,000 | 1.41% |
| NEXTHERA CAPITAL LP | 445,550 | $6,817,000 | 1.26% |
| DAFNA Capital Management LLC | 117,281 | $1,794,000 | 0.97% |
| PFM Health Sciences, LP | 1,752,124 | $26,807,000 | 0.64% |